INTERVIEW: Roche backing to help speed Liquid Biopsy's CTC test development
This article was originally published in Clinica
Executive Summary
Liquid Biopsy, a Swedish firm developing a test for circulating tumour cells (CTCs) for the diagnosis, prognosis and monitoring of cancer, has highlighted the importance of new partner Roche in developing the test for clinical use.